February 10, 2021
Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality
Media
February 10, 2021
Vicore Pharma has completed a directed share issue of SEK 336 million
February 09, 2021
Vicore Pharma intends to carry out a directed share issue
February 09, 2021
SOTIO has stopped collaboration trial with the dendritic cell vaccine DCVAC in combination with ONCOS-102
February 01, 2021
Positive data from Phase II study ATTRACT in patients with COVID-19 published online
January 29, 2021
Orexo expects FDA filing of OX124 mid 2022
January 28, 2021
Orexo Q4 2020, incl. Full Year Report
January 27, 2021
Orexo strengthens IP rights for overdose rescue drug OX124
January 19, 2021
InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation
January 13, 2021
GenSight Biologics Announces Publication of Results from LUMEVOQ® RESCUE Pivotal Phase III Trial in AAO journal Ophthalmology®
